Bessemer Group’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,263
Closed -$51K 2043
2023
Q4
$51K Hold
1,263
﹤0.01% 1334
2023
Q3
$49K Hold
1,263
﹤0.01% 1345
2023
Q2
$51K Hold
1,263
﹤0.01% 1370
2023
Q1
$53K Hold
1,263
﹤0.01% 1205
2022
Q4
$55K Hold
1,263
﹤0.01% 1130
2022
Q3
$49K Hold
1,263
﹤0.01% 1165
2022
Q2
$54K Hold
1,263
﹤0.01% 1092
2022
Q1
$57K Sell
1,263
-200
-14% -$8.86K ﹤0.01% 1053
2021
Q4
$71K Buy
1,463
+200
+16% +$9.47K ﹤0.01% 1062
2021
Q3
$60K Hold
1,263
﹤0.01% 1024
2021
Q2
$61K Hold
1,263
﹤0.01% 1032
2021
Q1
$58K Hold
1,263
﹤0.01% 983
2020
Q4
$60K Buy
+1,263
New +$57.3K ﹤0.01% 964

Other funds holding BME

Bessemer Group's BME Position: Q1 2024 in Review

Bessemer Group sold out of BlackRock Health Sciences Trust (BME) in Q1 2024, closing a stake of 1,263 shares — an estimated $51K sold.

Bessemer Group first reported a position in BME in Q4 2020 and held it in 13 quarters. The position peaked at $71K in Q4 2021. 74 funds tracked by Wall St. Rank hold BME as of Q1 2024.

  • Bessemer Group reported no remaining BlackRock Health Sciences Trust position as of Q1 2024 after selling out during the quarter.
  • Bessemer Group sold 1,263 BlackRock Health Sciences Trust shares in Q1 2024, an estimated $51K.
  • Bessemer Group first reported a position in BlackRock Health Sciences Trust in Q4 2020 and held it in 13 quarters.
  • Bessemer Group's BlackRock Health Sciences Trust position peaked at $71K in Q4 2021.
  • 74 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2024.

Based on Bessemer Group's 13F filing for Q1 2024, filed 13 May 2024.